Active	Status	Sponsor type	Region	Phase	Filter
11 Active 17 Inactive 28 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Köhrmann, Martin
ACTISAVE, NCT05070260 / 2021-002148-56: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo	Completed	2/3	438	Europe, US	Intravenous glenzocimab (ACT017) 1000 mg, Thrombolysis +/- thrombectomy, Intravenous Placebo	Acticor Biotech, ACTICOR BIOTECH	Acute Ischemic Stroke	04/24	04/24
Staykov, Dimitre
C-REGS2, NCT03480698: Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness	Active, not recruiting	N/A	1851	Europe	Cerebrolysin	Ever Neuro Pharma GmbH, IDV Data analysis and study planning Dr. Rahlfs	Acute Ischemic Stroke	04/24	10/24
Kuramatsu, Joji B
No trials found